MSB 2.70% 95.0¢ mesoblast limited

FDA ODAC Meeting Material discussion analysis, page-186

  1. 542 Posts.
    lightbulb Created with Sketch. 172
    Panel is out:

    Center for Drug Evaluation and Research (CDER)

    Page 1 of 2

    Oncologic Drugs Advisory Committee (ODAC) Roster Chairperson

    Philip C. Hoffman, MD

    Expertise: Medical Oncology

    Term: 4/25/2017 – 6/30/2021

    Professor of Medicine The University of Chicago

    Section of Hematology/Oncology

    Department of Medicine

    5841 S. Maryland Avenue, MC 2115

    Chicago, Illinois 60637

    Designated Federal Officer

    She-Chia S. Chen, PharmD

    Division of Advisory Committee and Consultant Management Office of Executive Programs

    Center for Drug and Evaluation and Research Food and Drug Administration 10903 New Hampshire Avenue

    Silver Spring, Maryland 20993 (301) 796-9001 Fax: (301) 847-8533

    E-mail: [email protected]

    1

    Jaffer A. Ajani, MD

    Expertise: Medical Oncology

    Term: 7/1/2019 – 6/30/2023

    Professor, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine

    Professor, Department of Epidemiology, Division

    of Office of the Vice President, Cancer Prevention and Population Sciences

    University of Texas MD Anderson Cancer Center

    1400 Holcombe Blvd., FC10.3022

    Houston, Texas 77030

    **Jonathan D. Cheng, MD

    Expertise: Medical Oncology

    Term: 11/1/2019 – 10/31/2023

    Vice President and Oncology Therapeutic Area Head, Merck Research Laboratories, Oncology Clinical Research

    351 North Sumneytown Pike

    North Wales, Pennsylvania 19454

    2

    Massimo Cristofanilli, MD, FACP

    Expertise: Medical Oncology

    Term: 9/27/2018 – 6/30/2022

    Associate Director of Translational Research and Precision Medicine

    Robert H. Lurie Comprehensive Cancer Center

    710 North Fairbanks Court, Suite 8-250A

    Chicago, Illinois 60611

    Jorge A. Garcia, MD, FACP

    Expertise: Medical Oncology

    Term: 7/1/2019 – 6/30/2023

    Chair, Division of Solid Tumor Oncology

    George and Edith Richman Distinguished Scientist Chair

    Director, GU Oncology Program

    University Hospitals Seidman Cancer Center

    Case Comprehensive Cancer Center

    Case Western Reserve University

    11100 Euclid Avenue, Lakeside Suite 1200

    Cleveland, Ohio 44106

    3

    Susan Halabi, PhD

    Expertise: Biostatistics

    Term: 7/1/2017 – 6/30/2021

    Professor of Biostatistics and Bioinformatics

    Duke University Medical Center

    2424 Erwin Road, Suite 11088

    Durham, North Carolina 27705

    Christian S. Hinrichs, MD

    Expertise: Medical Oncology

    Term: 9/27/2018 – 6/30/2022

    Investigator & Lasker Clinical Research Scholar

    Experimental Transplantation and Immunology

    Branch

    National Cancer Institute

    National Institutes of Health

    10 Center Drive, Room 4B04

    *David E. Mitchell

    Expertise: Consumer Representative

    Term: 10/22/2019 – 6/30/2024

    Founder, Patients for Affordable Drugs

    Bethesda, Maryland 20814

    Alberto S. Pappo, MD

    Expertise: Pediatric Oncology

    Term: 6/4/2015 – 6/30/2022

    Member and Head, Division of Solid Malignancies

    St Jude Children’s Research Hospital

    Professor of Pediatrics

    University of Tennessee Health Science Center

    262 Danny Thomas Place

    Memphis, Tennessee 38105

    1

    Anthony D. Sung, MD

    Expertise: Hematology

    Term: 7/1/2019 – 6/30/2023

    Assistant Professor of Medicine

    Duke University School of Medicine

    Duke Adult Blood and Marrow Transplant Clinic

    2400 Pratt Street, Suite 9000, Room 9053

    Durham, North Carolina 27705

    * Consumer Representative

    ** Industry Representative (non-voting)

    Updated: August 4, 2020

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.